Callan Family Office LLC Makes New $441,000 Investment in STERIS plc $STE

Callan Family Office LLC purchased a new stake in shares of STERIS plc (NYSE:STE) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,836 shares of the medical equipment provider’s stock, valued at approximately $441,000.

Several other large investors have also made changes to their positions in STE. GAMMA Investing LLC lifted its stake in shares of STERIS by 58.2% during the first quarter. GAMMA Investing LLC now owns 1,810 shares of the medical equipment provider’s stock valued at $410,000 after acquiring an additional 666 shares during the period. Fifth Third Bancorp lifted its stake in shares of STERIS by 16.8% during the first quarter. Fifth Third Bancorp now owns 2,893 shares of the medical equipment provider’s stock valued at $656,000 after acquiring an additional 416 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in shares of STERIS by 11.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,078 shares of the medical equipment provider’s stock valued at $1,831,000 after acquiring an additional 801 shares during the period. Dynamic Advisor Solutions LLC lifted its stake in shares of STERIS by 23.6% during the first quarter. Dynamic Advisor Solutions LLC now owns 1,203 shares of the medical equipment provider’s stock valued at $273,000 after acquiring an additional 230 shares during the period. Finally, Sagespring Wealth Partners LLC lifted its stake in shares of STERIS by 12.4% during the first quarter. Sagespring Wealth Partners LLC now owns 5,255 shares of the medical equipment provider’s stock valued at $1,191,000 after acquiring an additional 578 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Up 1.0%

Shares of STERIS stock opened at $237.92 on Wednesday. STERIS plc has a 1 year low of $200.98 and a 1 year high of $253.00. The business has a 50-day moving average of $244.75 and a two-hundred day moving average of $236.07. The company has a market capitalization of $23.43 billion, a P/E ratio of 36.43 and a beta of 1.01. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.32 by $0.02. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same period in the prior year, the company earned $2.03 earnings per share. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. As a group, equities analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Investors of record on Thursday, September 4th were issued a dividend of $0.63 per share. The ex-dividend date was Thursday, September 4th. This is a boost from STERIS’s previous quarterly dividend of $0.57. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.1%. STERIS’s dividend payout ratio is 38.59%.

Analysts Set New Price Targets

STE has been the topic of several research reports. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Tuesday. KeyCorp upped their price target on STERIS from $277.00 to $288.00 and gave the company an “overweight” rating in a research note on Tuesday, July 22nd. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Finally, Morgan Stanley upped their price objective on STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a report on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $273.50.

Insider Buying and Selling at STERIS

In related news, CAO Karen L. Burton sold 7,900 shares of the stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $241.73, for a total transaction of $1,909,667.00. Following the completion of the transaction, the chief accounting officer directly owned 5,994 shares in the company, valued at approximately $1,448,929.62. This trade represents a 56.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Mohsen Sohi sold 4,110 shares of the stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $241.96, for a total value of $994,455.60. Following the transaction, the director owned 22,361 shares of the company’s stock, valued at approximately $5,410,467.56. The trade was a 15.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 18,868 shares of company stock valued at $4,585,389 in the last 90 days. 1.07% of the stock is currently owned by corporate insiders.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.